John C Lucas - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

John C Lucas

Showing results (21-30 of 23) with videos related to

Pageof 3

Sort By:

You have reached the last page of results.This site can display upto 23 results.

Bioorganic & Medicinal Chemistry Letters|October 16, 2004

Discovery and SAR of 2-aminothiazole inhibitors of cyclin-dependent kinase 5/p25 as a potential treatment for Alzheimer's diseaseChristopher J Helal, Mark A Sanner, Christopher B Cooper, et al.

Bioorganic & Medicinal Chemistry Letters|August 25, 2009

Potent and cellularly active 4-aminoimidazole inhibitors of cyclin-dependent kinase 5/p25 for the treatment of Alzheimer's diseaseChristopher J Helal, Zhijun Kang, John C Lucas, et al.

The Journal of Organic Chemistry|November 7, 2012

Synthesis of spiropiperidine lactam acetyl-CoA carboxylase inhibitorsKim Huard, Scott W Bagley, Elnaz Menhaji-Klotz, et al.

Pageof 3

Search research articles

Showing results (21-30 of 23) with videos related to

Sort By:

Pageof 3

You have reached the last page of results.This site can display upto 23 results.

Bioorganic & Medicinal Chemistry Letters|October 16, 2004

Discovery and SAR of 2-aminothiazole inhibitors of cyclin-dependent kinase 5/p25 as a potential treatment for Alzheimer's diseaseChristopher J Helal, Mark A Sanner, Christopher B Cooper, et al.

Bioorganic & Medicinal Chemistry Letters|August 25, 2009

Potent and cellularly active 4-aminoimidazole inhibitors of cyclin-dependent kinase 5/p25 for the treatment of Alzheimer's diseaseChristopher J Helal, Zhijun Kang, John C Lucas, et al.

The Journal of Organic Chemistry|November 7, 2012

Synthesis of spiropiperidine lactam acetyl-CoA carboxylase inhibitorsKim Huard, Scott W Bagley, Elnaz Menhaji-Klotz, et al.

Pageof 3